| FORM 990, PART I, LINE 1 & PART III, LINE 1: |
|
THE MASSACHUSETTS EYE AND EAR INFIRMARY ("THE INFIRMARY") IS A NOT-FOR-PROFIT TEACHING HOSPITAL CONDUCTING PATIENT CARE AND RESEARCH. THE INFIRMARY IS A TEACHING HOSPITAL OF HARVARD MEDICAL SCHOOL AND AN INTERNATIONAL CENTER FOR RESEARCH. IT HAS THE MOST COMPETITIVE PROGRAM IN THE COUNTRY FOR EYE, EAR, NOSE, AND THROAT RESIDENCY TRAINING AND THE WORLD'S LARGEST OPHTHALMIC FELLOWSHIP PROGRAM. IT IS PART OF A SYSTEM OF RELATED ENTITIES THAT PROVIDE SPECIALIZED MEDICAL CARE COLLECTIVELY KNOWN AS "MASSACHUSETTS EYE AND EAR INFIRMARY" ("MEEI"). |
| FORM 990, PART VI, LINE 1A: |
THE INFIRMARY'S BYLAWS STATE THE FOLLOWING: |
THERE SHALL BE AN EXECUTIVE COMMITTEE CONSISTING OF THOSE INDIVIDUALS WHO ARE SERVING AS MEMBERS OF THE EXECUTIVE COMMITTEE OF THE MEMBER. THE EXECUTIVE COMMITTEE SHALL HAVE THE POWER TO TRANSACT ALL EMERGENCY BUSINESS OF THE CORPORATION DURING THE PERIOD BETWEEN THE MEETINGS OF THE BOARD OF DIRECTORS. THE EXECUTIVE COMMITTEE SHALL ALSO TRANSACT SUCH BUSINESS, PERFORM SUCH DUTIES, AND EXERCISE SUCH POWERS AS MAY BE DIRECTED OR DELEGATED BY THE BOARD OF DIRECTORS FROM TIME TO TIME. THE EXECUTIVE COMMITTEE SHALL KEEP A RECORD OF ITS PROCEEDINGS. ALL ACTIONS OF THE EXECUTIVE COMMITTEE SHALL BE REPORTED TO THE BOARD OF DIRECTORS AT ITS NEXT REGULAR MEETING. |
| FORM 990, PART VI, LINE 7A: |
|
THE GOVERNOR OF THE COMMONWEALTH HAS THE AUTHORITY TO APPOINT TWO DIRECTORS. THE BYLAWS OF THE INFIRMARY STATE THAT THE REMAINING DIRECTORS ARE THOSE INDIVIDUALS SERVING AS DIRECTORS OF ITS SOLE MEMBER, THE FOUNDATION OF THE MASSACHUSETTS EYE AND EAR INFIRMARY, INC. ("THE FOUNDATION"). |
| FORM 990, PART VI, LINE 7B: |
|
THE FOUNDATION IS THE SOLE MEMBER OF THE INFIRMARY AND RETAINS THE AUTHORITY TO MAKE DECISIONS REGARDING THE INFIRMARY. |
| FORM 990, PART VI, LINE 11B: |
|
THE INFIRMARY'S FORM 990 IS PREPARED BY PRICEWATERHOUSECOOPERS, LLP USING INFORMATION PREPARED BY MANAGEMENT. AFTER THE FORM 990 IS COMPLETED, IT IS REVIEWED BY THE DIRECTOR OF FINANCE OPERATIONS. THE FORM 990 IS THEN PRESENTED TO THE FINANCE COMMITTEE FOR REVIEW AND APPROVAL AS AUTHORIZED BY THE BOARD OF DIRECTORS. THE BOARD OF DIRECTORS ARE ALSO GIVEN THE FORM 990 FOR REVIEW WITH TIME TO SUBMIT COMMENTS AND QUESTIONS BEFORE FINAL FILING. |
| FORM 990, PART VI, LINE 12C: |
|
MEMBERS OF THE STAFF ARE REQUIRED TO DISCLOSE CONFLICTS OF INTEREST TO THEIR CHIEF OF SERVICE OR DEPARTMENT AND DIRECTOR OF LABORATORY/UNIT. MEMBERS OF THE BOARD OF DIRECTORS ARE REQUIRED TO DISCLOSE ANNUALLLY, IN WRITING, ANY INTERESTS THAT COULD GIVE RISE TO CONFLICTS. THE OFFICE OF THE INTERNAL AUDITOR OBTAINS AND REVIEWS THE ANNUAL CONFLICTS OF INTEREST STATEMENTS SUBMITTED BY MEMBERS OF THE BOARD OF DIRECTORS, AND REPORTS ON THE SAME TO THE AUDIT AND COMPLIANCE COMMITTEE OF THE BOARD. WITH RESPECT TO INTERESTS DISCLOSED BY BOARD MEMBERS THAT COULD GIVE RISE TO CONFLICTS OF INTEREST, THE INTERNAL AUDITOR REVIEWS ALL TRANSACTIONS BETWEEN SUCH INTERESTS AND AFFILIATES OF THE INFIRMARY, TO DETERMINE WHETHER THESE TRANSACTIONS WERE CONDUCTED AT ARM'S LENGTH. |
| FORM 990, PART VI, LINE 15: |
|
THE CHAIRMAN OF THE COMPENSATION COMMITTEE OF THE BOARD OF THE INFIRMARY PRESENTS A RECOMMENDATION TO THE COMPENSATION COMMITTEE WHO HAVE FINAL APPROVAL OF THE CEO'S BASE SALARY AND BONUS AMOUNT. THE CEO RECOMMENDS EXECUTIVE SALARIES TO THE COMPENSATION COMMITTEE OF THE BOARD WHO HAS FINAL AUTHORIZATION TO APPROVE IT. TOTAL COMPENSATION FOR THE CEO, CHIEFS AND VICE PRESIDENTS, INCLUDING BONUS PAYMENTS, INCLUDING COMPARABILITY DATA, IS ANALYZED BY INDEPENDENT COMPENSATION CONSULTANTS AND IS DETERMINED TO BE REASONABLE. |
| FORM 990, PART VI, LINE 19: |
|
SUMMARIZED FINANCIAL STATEMENTS ARE AVAILABLE ON THE INFIRMARY'S WEBSITE: WWW.MASSEYEANDEAR.ORG. AUDITED FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST. THE INFIRMARY'S GOVERNING DOCUMENTS AND FORM 990 ARE AVAILABLE ON THE WEBSITE OF THE OFFICE OF ATTORNEY GENERAL AND ARE ALSO AVAILABLE UPON REQUEST. THE CONFLICT OF INTEREST POLICY IS ALSO AVAILABLE UPON REQUEST. FORM 990, PART VII: THE FOLLOWING INDIVIDUALS WORKED AT RELATED ORGANIZATIONS DURING THE YEAR ENDED SEPTEMBER 30, 2012: RICHARD ALDRICH - 2 HOURS DEWALT ANKENY - 5 HOURS JAVIER BALLOFFET - 20 HOURS LILY BENTAS - 9 HOURS JAMES CARLISLE - 2 HOURS CHARLES DE GUNZBURG - 5 HOURS JOHN FERNANDEZ - 24 HOURS SAMUEL FLEMING - 4 HOURS HARVEY FREISHTAT - 4 HOURS WYCLIFFE GROUSBECK - 4 HOURS JOSEPH W. HALEY - 6 HOURS KENNETH HOLMES - 30 HOURS LYLE HOWLAND - 2 HOURS DIANE KANEB - 2 HOURS MAUREEN KELLEY - 10 HOURS JONATHAN KUTCHINS - 4 HOURS ALAN K. LONG - 30 HOURS JEAN E. MACQUIDDY - 30 HOURS VICTORIA MCCULLOUGH - 5 HOURS JOAN MILLER - 33 HOURS JOSEPH NADOL - 31 HOURS ANNETTE NOVA - 5 HOURS MELISSA PAUL - 50 HOURS CHRISTINE REGAN - 10 HOURS WILLIAM ROMAN - 4 HOURS BARBARA J. SCULLY - 30 HOURS JENNIFER STREET - 17 HOURS FREDERICK THORNE - 2 HOURS JONATHAN UHRIG - 7 HOURS KATHRYN VECELLIO - 5 HOURS CAROLANN WILLIAMS - 12 HOURS SUSAN WILLIAMS - 19 HOURS |
| FORM 990, PART XI, LINE 5: |
|
OTHER CHANGES IN NET ASSETS: NET UNREALIZED GAINS (LOSSES) ON INVESTMENTS $433,731 PENSION/POST-RETIREMENT CHARGE ($7,624,694) TOTAL OTHER CHANGES IN NET ASSETS ($7,190,963) |
| SCHEDULE K, PART I, BOND (A), COLUMN (F): |
|
THE PROJECT CONSISTS OF RENOVATION AND IMPROVEMENT OF EXISTING SPACE AND ACQUISITION OF MISCELLANEOUS EQUIPMENT LOCATED IN MEEI'S MAIN CLINICAL BUILDING, INCLUDING BUT NOT LIMITED TO THE FOLLOWING: THE AMBULATORY AND INPATIENT OPERATING ROOMS, THE SINUS CLINIC, THE NEURO-OPTHALMOLOGY CLINIC, THE OTOLARYNGOLOGY LASER CENTER, THE ENT CLINIC FOCUSING ON HEAD AND NECK CONDITIONS, THE PRE-ADMISSION TESTING SUITE, THE OPHTHALMOLOGY OUTPATIENT CLINICS LOCATED ON THE FIRST FLOOR, THE GROUND FLOOR (INCLUDING THE LOBBY AREA, EMERGENCY DEPARTMENT AND RADIOLOGY DEPARTMENT), THE PEDIATRIC OPHTHALMOLOGY CLINIC, THE HEAD AND NECK CLINIC, THE LASER CENTER, THE PEDIATRIC INPATIENT UNIT, THE OPHTHALMOLOGY PLASTICS OUTPATIENT CLINIC, THE OTOLARYNGOLOGY FACULTY OFFICE SUITE AND THE DESIGN AND ARCHITECTURAL FEES RELATING TO THE RECONSTRUCTING OF THE GROUND, FIRST, SECOND AND THIRD FLOORS FOR ADDITIONAL CLINICAL SPACE. IMPROVEMENTS TO EXISTING BUILDING INFRASTRUCTURE. PLANNING AND DESIGN COSTS RELATED TO A REPLACEMENT RESEARCH OR CLINICAL BUILDING TO BE LOCATED AT 309-325 CAMBRIDGE STREET. COSTS OF ISSUANCE AND CAPITALIZED INTEREST ON THE BONDS FINANCING THE PROJECTS DESCRIBED IN THIS SECTION FOR A PERIOD OF UP TO THREE YEARS. |
| SCHEDULE K, PART I, BOND (B), COLUMN (F): |
|
THE PROJECT ALL TO BE OWNED AND OPERATED BY THE INFIRMARY, CONSISTS GENERALLY OF (A) RENOVATION OF THE OUTPATIENT AREAS OF THE INFIRMARY AND OF THE 7TH FLOOR SERVICE AREA AND OFFICES, ALL LOCATED AT 243 CHARLES STREET, BOSTON, MASSACHUSETTS, AND (B) EQUIPMENT PURCHASES. |
| SCHEDULE K, PART I, BOND (C), COLUMN (F): |
|
THE PROJECT ALL TO BE OWNED AND OPERATED BY THE INFIRMARY, CONSISTS GENERALLY OF (A) RENOVATION OF THE OUTPATIENT AREAS OF THE INFIRMARY AND OF THE 7TH FLOOR SERVICE AREA AND OFFICES, ALL LOCATED AT 243 CHARLES STREET, BOSTON, MASSACHUSETTS, AND (B) EQUIPMENT PURCHASES. |
| PART III - PROGRAM SERVICE, LINE 4A |
|
RESEARCH OVERALL: (FROM ADVANCING RESEARCH SECTION OF THE PRINTED ANNUAL REPORT) OUR RESEARCHERS CONTINUED TO MAKE ADVANCES THAT HAVE THE POTENTIAL TO CHANGE THE LANDSCAPE OF HEALTHCARE IN THE YEARS TO COME. THE FOLLOWING ARE JUST A FEW EXAMPLES. - ALBERT EDGE, PH.D., DEMONSTRATED FOR THE FIRST TIME THAT HAIR CELLS CAN BE REGENERATED IN AN ADULT MAMMALIAN EAR BY USING A DRUG TO STIMULATE RESIDENT CELLS TO BECOME NEW HAIR CELLS, RESULTING IN PARTIAL RECOVERY OF HEARING IN MOUSE EARS DAMAGED BY NOISE TRAUMA. THIS FINDING HOLDS GREAT POTENTIAL FOR FUTURE THERAPEUTIC APPLICATION THAT MAY SOMEDAY REVERSE DEAFNESS IN HUMANS. - DR. KONSTANTINA STANKOVIC, IN COLLABORATION WITH ANANTHA P. CHANDRAKASAN, PH.D., FROM THE MASSACHUSETTS INSTITUTE OF TECHNOLOGY, WAS THE FIRST TO EXTRACT ENERGY FROM THE "BIOLOGIC BATTERY" IN THE INNER EAR TO POWER ELECTRONICS WITHOUT DAMAGING HEARING, SETTING THE STAGE FOR FUTURE DEVICES THAT ARE SELF-POWERING. - A FEW YEARS AGO, SHARON G. KUJAWA, PH.D. AND M. CHARLES LIBERMAN, PH.D., DISCOVERED THAT OVEREXPOSURE TO MODERATE LEVELS OF NOISE CAN CAUSE DEGENERATION OF COCHLEAR NERVE FIBERS, EVEN IF THE HEARING THRESHOLDS (AND COCHLEAR HAIR CELLS) COMPLETELY RECOVER. THIS YEAR, DRS. KUJAWA AND LIBERMAN, ALONG WITH GRADUATE STUDENT ADAM FURMAN, SHOWED THAT THIS DEGENERATION IS SELECTIVE FOR THE HIGH-THRESHOLD NEURONS THAT NORMALLY HELP US HEAR IN A NOISY ENVIRONMENT. WE THINK THIS HELPS EXPLAIN WHY THE ABILITY TO HEAR IN NOISY SETTINGS DETERIORATES IN THE AGING EAR. - DR. KATHRYN COLBY PERFORMED FIRST COLLAGEN CROSS-LINKING IN BOSTON, AN EXPERIMENTAL TREATMENT FOR KERATOCONUS, UNDER THE AUSPICES OF AN FDA-SANCTIONED CLINICAL TRIAL. - RESEARCHERS FROM THE MASS. EYE AND EAR, THE CHILDREN'S HOSPITAL OF PHILADELPHIA, AND LOYOLA UNIVERSITY CHICAGO HEALTH SCIENCES DIVISION AND THEIR COLLABORATORS ISOLATED AN ELUSIVE HUMAN GENE THAT CAUSES A COMMON FORM OF LEBER CONGENITAL AMAUROSIS (LCA), A RELATIVELY RARE BUT DEVASTATING FORM OF EARLY-ONSET BLINDNESS. THE NEW LCA GENE IS CALLED NMNAT1. FINDING THE SPECIFIC GENE MUTATED IN PATIENTS WITH LCA IS THE FIRST STEP TOWARDS DEVELOPING SIGHT-SAVING GENE THERAPY. DR. ERIC PIERCE, DIRECTOR OF THE OCULAR GENOMICS INSTITUTE, IS A CO-SENIOR AUTHOR ON THE STUDY. - RESULTS FROM THE LARGEST GENETIC STUDY OF GLAUCOMA, A LEADING CAUSE OF BLINDNESS AND VISION LOSS WORLDWIDE, SHOWED THAT TWO GENETIC VARIATIONS ARE ASSOCIATED WITH PRIMARY OPEN-ANGLE GLAUCOMA, A COMMON FORM OF THE DISEASE. THE IDENTIFICATION OF GENES RESPONSIBLE FOR THIS DISEASE IS THE FIRST STEP TOWARD THE DEVELOPMENT OF GENE-BASED DISEASE DETECTION AND TREATMENT. RESEARCHERS INCLUDED STUDY LEAD AUTHOR DR. JANEY WIGGS AND CO-SENIOR AUTHOR DR. LOU PASQUALE. MORE THAN 128 RESEARCH PROPOSALS WERE FUNDED THIS YEAR, FOR A TOTAL OF $24,853,997, WITH 69 NEW GRANT AWARDS. IN FY12, MASS. EYE AND EAR ONCE AGAIN RANKED AMONG THE TOP NIH-FUNDED RESEARCH INSTITUTIONS IN THE UNITED STATES. WE ALSO RECEIVED FUNDING FROM CORPORATIONS AND FOUNDATIONS WHICH HELP US ADVANCE THE WORK WE DO TO FIND CURES. WE EXTEND OUR APPRECIATION TO ALL INDIVIDUALS AND ORGANIZATIONS THAT HAVE FUNDED OUR RESEARCH EFFORTS. OPHTHALMOLOGY: OUR RESEARCH EFFORTS FORGED AHEAD MARKED BY TWO SIGNIFICANT MILESTONES - THE FIRST COMBINED MEE/SCHEPENS ANNUAL RESEARCH FACULTY RETREAT AND THE APPOINTMENT OF PATRICIA D'AMORE, PHD, MBA, FARVO TO DIRECTOR OF RESEARCH AT SCHEPENS. WE ARE ALSO MAKING SIGNIFICANT HEADWAY IN ESTABLISHING OUR OCULAR GENOMICS INSTITUTE (OGI) AS A BURGEONING CENTER OF EXCELLENCE FOR GENOMICS AND GENE THERAPY RESEARCH; PROMISING TRANSLATIONAL INVESTIGATIONS ARE UNDERWAY IN THE INSTITUTE AND THE BERMAN GUND LABORATORY FOR THE STUDY OF RETINAL DEGENERATIONS, AND ALREADY YIELDING EXCITING RESULTS. RESEARCH MILESTONE PATRICIA A. D'AMORE, PHD, MBA, FARVO IS NAMED SCHEPENS DIRECTOR OF RESEARCH FOLLOWING AN INTERNATIONAL SEARCH, PATRICIA D'AMORE, PHD, MBA, FARVO WAS NAMED DIRECTOR OF RESEARCH AT SCHEPENS EYE RESEARCH INSTITUTE, EFFECTIVE NOVEMBER 1, 2012. DR. D'AMORE IS PROFESSOR OF OPHTHALMOLOGY AND PATHOLOGY AT HARVARD MEDICAL SCHOOL (HMS), HMS OPHTHALMOLOGY VICE CHAIR OF BASIC RESEARCH, AND SENIOR SCIENTIST AND ANKENY SCHOLAR OF RETINAL MOLECULAR BIOLOGY AT SCHEPENS. AS DIRECTOR, DR. D'AMORE WILL SERVE AS THE SENIOR LEADER AT SCHEPENS AND AS A MEMBER OF THE MASS. EYE AND EAR RESEARCH LEADERSHIP TEAM, REPORTING TO CHIEF AND CHAIR, DR. JOAN MILLER, AND TO THE SCHEPENS BOARD OF DIRECTORS. DR. D'AMORE WILL ALSO BE NOMINATED FOR APPOINTMENT AS THE CHARLES L. SCHEPENS PROFESSOR OF OPHTHALMOLOGY AT HMS. DR. D'AMORE'S SELECTION FOLLOWS A RIGOROUS, EIGHT-MONTH EFFORT BY AN HMS-APPOINTED SEARCH COMMITTEE TO IDENTIFY A HIGHLY ACCOMPLISHED ACADEMIC AND SCIENTIFIC LEADER WHO HAS ACHIEVED SIGNIFICANT SUCCESS IN ADVANCING THE FIELD OF VISION SCIENCE. NEW EQUIPMENT & TECHNOLOGY FOR RESEARCH - SCHEPENS EYE RESEARCH INSTITUTE MORPHOLOGY CORE - LEICA PT 2030 AUTOMATIC TISSUE PROCESSOR FOR USE IN HISTOPATHOLOGY APPLICATIONS. - SCHEPENS EYE RESEARCH INSTITUTE RETINAL GENE TRANSFER CORE - BIOSAFETY CABINETS, ULTRACENTRIFUGE, AND INCUBATORS FOR VECTOR PRODUCTION - SCHEPENS EYE RESEARCH INSTITUTE TWO-PHOTON CONFOCAL MICROSCOPE CORE - MICROVIDEO INSTRUMENTS INTRAVITAL MICROSCOPE - MACPRO TWO AND BITPLANE SCIENTIFIC IMARIS SOFTWARE FOR IMAGE ANALYSIS - OCULAR GENOMICS INSTITUTE - CLIA DIAGNOSTIC LABORATORY AND DNA SEQUENCING CORE - ILLUMINA ISCAN AND MISEQ SYSTEMS AND LIFE TECHNOLOGIES 3730XL DNA ANALYZER - THERMAL CYCLERS FOR RESEARCH AND CLINICAL DNA SEQUENCE ANALYSIS NEW SERVICE/RENOVATIONS - NEW LABORATORIES HAVE BEEN ESTABLISHED AT SCHEPENS FOR LOTFI MERABET, OD, PHD, LUK VANDENBERGHE, PHD, AND PEDRAM HAMRAH, MD, PHD RESEARCH SUCCESSES CORNEA - COMPLETED A CLINICAL STUDY EVALUATING THE EFFICACY OF A TOPICAL COMBINED ANTI-PDGF AND ANTI-VEGF THERAPY IN CORNEAL ANGIOGENESIS. - CREATED AND VALIDATED AN OCULAR REDNESS CONTINUOUS (0.0 - 100.0) SCALE USING A NOVEL, STATE-OF-THE-ART COMPUTER PROGRAM. - RECEIVED A GRANT FROM THE DEPARTMENT OF DEFENSE TO CONDUCT A MULTI-CENTER CLINICAL TRIAL TO ASSESS THE SAFETY AND EFFICACY OF A ANTI-VEGF IN PATIENTS WHO ARE AT HIGH-RISK FOR GRAFT REJECTION FOLLOWING THEIR CORNEAL TRANSPLANT. - COMPLETED A STUDY ASSESSING THE USE OF TEAR OSMOLARITY AS A NEW METHOD TO DIAGNOSE AND MONITOR DRY EYE DISEASE. - DEVELOPED TELOMERASE-IMMORTALIZED CORNEAL ENDOTHELIAL CELL LINE WHICH WILL PROVIDE A NEW TOOL FOR THE IN VITRO STUDY OF CORNEAL ENDOTHELIAL CELL BIOLOGY AND WILL BE MADE AVAILABLE TO THE NIH COMMUNITY. - DETERMINED THAT DEFICIENCY IN NRF2-REGULATED PATHWAY IS INVOLVED IN THE PATHOGENESIS OF FUCHS ENDOTHELIAL CORNEAL DYSTROPHY. - DETERMINED THAT CORNEAL LIMBAL FIBROBLASTS CAN BE DIFFERENTIATED INTO CORNEAL EPITHELIAL CELLS THUS SERVING AS A NOVEL SOURCE OF CORNEAL EPITHELIUM USUALLY DESTROYED IN LIMBAL STEM CELL DEFICIENCY DISORDERS. - DEMONSTRATED THE PRESENCE OF THE INTEGRIN MADCAM-1 IN THE OCULAR SURFACE VASCULATURE AND DETERMINED ITS ROLE IN THE RECRUITMENT OF CORNEAL IMMUNE CELLS. - FIRST HUMAN IMPLANTATION OF AN INTRAOCULAR DEVICE TO MEASURE IOP BY TELEMETRY. THIS MAY RESOLVE THE INABILITY TO MEASURE IOP IN KERATOPROSTHESIS PATIENTS. - CONDUCTED THE FIRST LARGE SCALE CATARACT SURGERY OUTCOMES REVIEW (18,000 CASES) IN THE UK INDEPENDENT SECTOR. - DEMONSTRATED WITH LIVE CORNEAL IMAGING THAT UNILATERAL CORNEAL INFECTIONS, INCLUDING IN HERPES ZOSTER OPHTHALMICUS, LEAD TO CONTRALATERAL CHANGES IN CORNEAL NERVES IN THE UNAFFECTED EYE, SUGGESTING NEURO-REGULATORY MECHANISMS BETWEEN EYES. - DEMONSTRATED THAT A DRUG-ELUTING CONTACT LENS CAN DELIVER A THERAPEUTIC AMOUNT OF A GLAUCOMA MEDICATION FOR ONE MONTH. - DETERMINED THAT DEVICES USED IN PROSE TREATMENT CAN BE CUSTOMIZED TO ACCOMMODATE ANY EYE WITH KERATOCONUS OR POST-LASIK ECTASIA REGARDLESS OF DISEASE SEVERITY. - PERFORMED FIRST COLLAGEN CROSS-LINKING IN BOSTON, AN EXPERIMENTAL TREATMENT FOR KERATOCONUS, UNDER THE AUSPICES OF AN FDA-SANCTIONED CLINICAL TRIAL. |
| BOSTON KERATOPROSTHESIS (KPRO) |
|
- IN A LARGE WORLDWIDE SURVEILLANCE STUDY, 4610 KPRO IMPLANTATIONS BY 368 SURGEONS, THERE WERE 176 INCIDENTS (3.8%) OF ENDOPHTHALMITIS. IN CONTRAST, IN A BOSTON (LOCAL) SERIES OF 271 KPRO CASES PERFORMED FROM 2000-2009, ONLY 3 CASES (1.1%) OF BACTERIAL ENDOPHTHALMITIS OCCURRED. NEW HIGHLY EFFECTIVE, LOW-COST ANTIBIOTICS COMBINATIONS FOR ONCE-DAILY PROPHYLAXIS HAVE BEEN PROPOSED. - IN A CLINICAL STUDY ON ALKALI BURNS, THE BOSTON KPRO WAS SHOWN TO HAVE GOOD RETENTION, BUT SEVERE GLAUCOMA OFTEN RUINED THE OPTIC NERVE. EXPERIMENTS ON EX VIVO PIG EYES AND IN VIVO MOUSE EYES SHOWED THAT THE GLAUCOMA WAS NOT CAUSED BY BACKWARDS DIFFUSION OF THE ALKALI ITSELF. RATHER, IT SEEMS THAT EASILY DIFFUSIBLE INFLAMMATORY CYTOKINES CAN REACH THE GANGLION CELL LAYER AND CAUSE WIDESPREAD APOPTOSIS WITHIN 24 HOURS. OF POTENTIAL PRACTICAL IMPORTANCE WAS THE ADDITIONAL FINDING THAT INFLIXIMAD (REMICADE) HAS A VERY STRONG PROTECTIVE EFFECT, BOTH ANTERIORLY AND POSTERIORLY. IT IS THUS POSSIBLE THAT PATIENTS WITH SEVERE CHEMICAL BURNS, WHEN THEY REACH AN EMERGENCY ROOM, SHOULD ALSO HAVE AN IMMEDIATE INTRAVENOUS INFUSION OF INFLIXIMAB. - DEMONSTRATED BETTER WOUND ANATOMY FOLLOWING BOSTON KPRO SURGERY USING LARGER BACKPLATES, SUGGESTING ONE SOLUTION TO THE PROBLEM OF RETROPROSTHETIC MEMBRANE FORMATION. RETINA - FOR THE FIRST TIME IDENTIFIED THE MODE OF DEATH OF CONE PHOTORECEPTOR CELLS IN AN ANIMAL MODEL OF RETINITIS PIGMENTOSA. THIS RESEARCH HAS FURTHER IDENTIFIED THE RECEPTOR INTERACTING PROTEIN KINASE PATHWAY AS A POTENTIAL TARGET FOR DEVELOPING TREATMENT FOR VISION LOSS IN PATIENTS WITH RP. - INVESTIGATE THE ANTI-INFLAMMATORY ACTION OF THE EXERCISE MIMETIC ACADESINE, A MEDICATION THAT ACTIVATES AMP KINASE, AND SHOWED THAT IT SUPPRESSES OCULAR INFLAMMATION IN AN ANIMAL MODEL OF AUTOIMMUNE UVEITIS - RESEARCHERS FROM THE ANGIOGENESIS LABORATORY HIGHLIGHTED THAT A COMMONLY USED STRAIN OF LABORATORY ANIMALS USED IN RETINAL RESEARCH EXHIBIT BASELINE PATHOLOGY THAT CAN ALTER THE CONCLUSIONS OF OTHER STUDIES. - DR. DEAN ELIOTT RECEIVED APPROVAL FOR A PHASE I/II TRIAL IS A PROSPECTIVE, OPEN-LABEL STUDY DESIGNED TO DETERMINE THE SAFETY AND TOLERABILITY OF THE HUMAN EMBRYONIC STEM CELLS-DERIVED RPE CELLS FOR SUB-RETINAL TRANSPLANTATION INTO PATIENTS WITH DRY AMD. - RESEARCHERS FROM THE MASS. EYE AND EAR, THE CHILDREN'S HOSPITAL OF PHILADELPHIA, LOYOLA UNIVERSITY CHICAGO HEALTH SCIENCES DIVISION AND THEIR COLLABORATORS HAVE ISOLATED AN ELUSIVE HUMAN GENE THAT CAUSES A COMMON FORM OF LEBER CONGENITAL AMAUROSIS (LCA), A RELATIVELY RARE BUT DEVASTATING FORM OF EARLY-ONSET BLINDNESS. THE NEW LCA GENE IS CALLED NMNAT1. FINDING THE SPECIFIC GENE MUTATED IN PATIENTS WITH LCA IS THE FIRST STEP TOWARDS DEVELOPING SIGHT-SAVING GENE THERAPY. ERIC PIERCE, MD, PHD, DIRECTOR OF THE OCULAR GENOMICS INSTITUTE IS A CO-SENIOR AUTHOR ON THE STUDY. - ADMINISTRATION OF A GENE THERAPY VECTOR CARRYING THE RPE65 GENE TO ONE EYE IN EACH OF 12 PATIENTS WITH CONGENITAL BLINDNESS DUE TO RPE65 MUTATIONS LED TO IMPROVEMENTS IN RETINAL AND VISUAL FUNCTION AND PROVED TO BE A SAFE AND STABLE PROCEDURE. - ANALYZED VISUAL ACUITY DATA FROM THREE CLINICAL TRIALS CONDUCTED INVOLVING PATIENTS WITH TYPICAL RETINITIS PIGMENTOSA TO SHOW THAT A DIET RICH IN OMEGA-3 FATTY ACIDS APPEARS ASSOCIATED WITH SLOWING VISUAL ACUITY DECLINE IN RETINITIS PIGMENTOSA PATIENTS ON VITAMIN A. - DISCOVERY THAT VEGG, WHICH IS KNOWN TO CAUSE BLOOD VESSEL GROWTH, ALSO SEEMS TO UNEXPECTEDLY BIND THE RECEPTOR FOR ANOTHER GROWTH FACTOR KNOWN AS PLATELET-DERIVED GROWTH FACTOR (PDGF), AND PREVENT PDGF FROM BINDING. THIS SUGGESTS THAT VEGF MAY CONTRIBUTE TO THE DEVELOPMENT OF PROLIFERATIVE VITREORETINOPATHY, THE MOST COMMON SERIOUS SIDE-EFFECT OF RETINAL RE-ATTACHMENT SURGERY. GLAUCOMA - IN RESEARCH CONDUCTED WITH DR. JAE HEE KANG FROM THE CHANNING DIVISION OF NETWORK MEDICINE AT BRIGHAM AND WOMEN'S HOSPITAL, DR. PASQUALE REPORTED THAT HEAVY CONSUMPTION OF CAFFEINATED COFFEE IS ASSOCIATED WITH AN INCREASED RISK FOR EXFOLIATION GLAUCOMA OR EXFOLIATION GLAUCOMA SUSPECT. - RESULTS FROM THE LARGEST GENETIC STUDY OF GLAUCOMA, A LEADING CAUSE OF BLINDNESS AND VISION LOSS WORLDWIDE, SHOWED THAT TWO GENETIC VARIATIONS ARE ASSOCIATED WITH PRIMARY OPEN ANGLE GLAUCOMA, A COMMON FORM OF THE DISEASE. THE IDENTIFICATION OF GENES RESPONSIBLE FOR THIS DISEASE IS THE FIRST STEP TOWARD THE DEVELOPMENT OF GENE-BASED DISEASE DETECTION AND TREATMENT. RESEARCHERS INCLUDED STUDY LEAD AUTHOR JANEY WIGGS, MD, PHD, AND LOU PASQUALE, MD, FARVO. - RESEARCHERS FROM THE MASS. EYE AND EAR, BRIGHAM AND WOMEN'S HOSPITAL, AND UNIVERSITY OF MICHIGAN, ANN ARBOR, MICH., SET OUT TO FIND OUT HOW DEMOGRAPHIC AND GEOGRAPHIC RISK FACTORS ARE ASSOCIATED WITH ES. THEIR STUDY, THE "DEMOGRAPHIC AND GEOGRAPHIC FEATURES OF EXFOLIATION GLAUCOMA IN TWO UNITED STATES-BASED PROSPECTIVE COHORTS" WAS PUBLISHED IN THE JANUARY 2012 ISSUE OF OPHTHALMOLOGY. THIS STUDY CONFIRMED ESTABLISHED ASSOCIATIONS WITH AGE AND FAMILY HISTORY AND EXFOLIATION GLAUCOMA OR EXFOLIATION GLAUCOMA SUSPECT (EG/EGS), AS WELL AS PROVIDED NEW DATA ON ASSOCIATIONS WITH GENDER, EYE COLOR AND ANCESTRY. - DR. PASQUALE AND COLLEAGUES DESCRIBED OCULAR INJURY, INCLUDING GLAUCOMA, AFTER LASER PHOTOEPILATION TO REMOVE UNWANTED EYEBROW HAIR. THESE OCULAR INJURIES OCCURRED DESPITE PROTECTIVE EYEWEAR. THE AUTHORS REPORT THAT PREVENTIVE MEASURES THAT ACCOUNT FOR THE ROUNDED CONTOUR OF THE ORBITAL RIM ARE NEEDED TO PREVENT UNWANTED INTERACTION BETWEEN LASER ENERGY EMITTED FROM THE LASER PROBE AND INTRAOCULAR STRUCTURES DURING EYEBROW LASER PHOTOEPILATION. - FOR THE FIRST TIME, DR. TERESA CHEN DESCRIBED A CASE OF BILATERAL SECONDARY ANGLE CLOSURE GLAUCOMA AFTER BUPROPION (WELLBUTRIN) USE. - DR. JANEY WIGGS LED A GROUP OF RESEARCHERS TO DESCRIBE AN ASSOCIATION BETWEEN A COMMON POLYMORPHISM IN THE P53 GENE AND INITIAL PARACENTRAL VISION LOSS IN PRIMARY OPEN ANGLE GLAUCOMA. - WORK FROM THE ANGIOGENESIS LABORATORY INVESTIGATED THE PROTECTIVE ROLE OF THE TNF INHIBITOR, ETANERCEPT (ALSO KNOWN AS ENBREL, A MEDICATION USED FOR AUTOIMMUNE DISEASES SUCH AS RHEUMATOID ARTHRITIS) IN AN ANIMAL MODEL OF GLAUCOMA. |
| RESEARCH GRANTS |
|
TERESA CHEN, MD RECEIVED A HARVARD CATALYST PILOT GRANT AWARD FOR HER PROJECT, "SPECTRAL DOMAIN OCT 3D." JAMES CHODOSH, MD, MPH WAS AWARDED A RESEARCH TO PREVENT BLINDNESS SENIOR SCIENTIFIC INVESTIGATOR AWARD FOR HIS PROJECT, "ADENOVIRUS EVOLUTION & EMERGENCE OF NEW OCULAR PATHOGENS." DR. CHODOSH ALSO RECEIVED A NEW RESEARCH AGREEMENT AWARD FROM JANSSEN BIOTECH, INC. FOR HIS PROJECT: INFLIXIMAB THERAPY TO IMPROVE RETENTION OF THE BOSTON KERATOPROSTHESIS. JOSEPH CIOLINO, MD RECEIVED A 4-YEAR RESEARCH TO PREVENT BLINDNESS CAREER DEVELOPMENT AWARD. KIP CONNOR, PHD, HMS ASSISTANT PROFESSOR OF OPHTHALMOLOGY RECEIVED A NEW SUPPLEMENT FOR HIS R01 GRANT, "COMPLEMENT MEDIATED NEOVASCULARIZATION IN RETINOPATHY." DR. CONNOR WAS ALSO AWARDED A JANSSEN RESEARCH & DEVELOPMENT GRANT FOR HIS PROJECT: "HUTCS IN THE RETINA. REZA DANA, MD, MPH, MSC WAS AWARDED A FOUR YEAR, $2.3 MILLION COOPERATIVE AGREEMENT AWARD WITH THE DEPARTMENT OF DEFENSE: "SAFETY AND EFFICACY OF BEVACIZUMAB IN HIGH-RISK CORNEAL TRANSPLANT SURVIVAL." MICHAEL GILMORE, PHD RECEIVED A NEW RESEARCH AWARD FROM BAUSCH & LOMB FOR HIS PROJECT, "COMPARATIVE GENOMICS OF OCULAR PATHOGENS." TATJANA JAKOBS, MD RECEIVED A RESEARCH TO PREVENT BLINDNESS DOLLY GREEN SPECIAL SCHOLAR AWARD. ANN-MARIE LOBO, MD RECEIVED A GRANT FROM ABBVIE, INC. FOR HER STUDY, "A MULTICENTER STUDY OF THE EFFICACY AND SAFETY OF THE HUMAN ANTI-TNF MONOCLONAL ANTIBODY ADALIMUMAB AS MAINTENANCE THERAPY IN SUBJECTS REQUIRING HIGH DOSE CORTICOSTEROIDS FOR INACTIVE NON-INFECTIOUS INTERMEDIATE-, POSTERIOR-, OR PAN-UVEITIS." GANG LUO, PHD RECEIVED A WILLIAM F. MILTON FUND AT HARVARD UNIVERSITY AWARD, FOR HIS WORK, "SEEING IN BLIND FIELD IN VISUALLY IMPAIRED PEOPLE." RICHARD MASLAND, PHD, RECEIVED A TWO-YEAR GRANT FROM HMS FOR HIS PROJECT, "RETINAL GANGLION CELLS." LOTFI MERABET, OD, PHD, MPH RECEIVED A NEW SUPPLEMENT TO HIS NEI R01 GRANT, "AUDIO BASED NAVIGATION IN THE BLIND" LOUIS PASQUALE, MD, FARVO RECEIVED A GIFT OF $100,000 FROM MASS. EYE AND EAR SUPPORTER, MR. PAUL MARGOLIS FOR HIS PROJECT, "THE GENETICS OF RETINAL VASCULAR DYSREGULATION IN GLAUCOMA." ROBERTO PINEDA II, MD RECEIVED A HARVARD CATALYST PILOT GRANT AWARD FOR HIS PROJECT, "EARLY DETECTION OF CORNEAL EXTASIA THROUGH IN VIVO BRILLOUIN IMAGING." DOUGLAS RHEE, MD RECEIVED A NEW STUDY AGREEMENT AWARD FROM MERCK SHARP & DOHME CORPORATION FOR THE PROJECT, "EFFECT OF OPHTHALMIC PRESERVATIVES ON TRABECULAR MESHWORK OUTFLOW FACILITY." JOSEPH RIZZO III, MD RECEIVED A RESEARCH AWARD FROM THE VA BOSTON HEALTHCARE SYSTEM, FOR HIS PROJECT: "PENETRATING ELECTRODES IN THE BOSTON RETINAL PROSTHESIS." THE NATIONAL EYE INSTITUTE HAS AWARDED RESEARCHERS AT SCHEPENS A FIVE YEAR-GRANT TOTALING MORE THAN $2.4 MILLION TO UNDERSTAND THE ORIGINS OF EYE ALLERGIES, DANIEL SABAN, PHD, MS IS THE PRINCIPAL INVESTIGATOR FOR THE PROJECT ENTITLED "CELLULAR AND MOLECULAR MECHANISMS THAT CONTRIBUTED TO OCULAR SURFACE ALLERGY." LUCY Q. SHEN RECEIVED A YOUNG CLINICIAN SCIENTIST AWARD FROM THE AMERICAN GLAUCOMA SOCIETY FOR HER PROJECT, "USING STRUCTURE-FUNCTION RELATIONSHIP TO AID THE DIAGNOSIS AND MONITORING OF GLAUCOMA." DIMITRA SKONDRA, MD, MASS. EYE AND EAR VITREORETINAL FELLOW, WAS NAMED THE 2012 ALCON CLINICAL RESEARCH SCHOLAR. THIS AWARD IS GRANTED TO A CLINICAL RESEARCH FELLOW TO SUPPORT A CERTIFIED OR BOARD ELIGIBLE SUBSPECIALTY FELLOWSHIP CANDIDATE FOR A ONE-YEAR STRUCTURED CLINICAL AND RESEARCH DEVELOPMENT PROGRAM UNDER MENTORSHIP OF A SENIOR HMS FACULTY MEMBER. LUCIA SOBRIN, MD, MPH RECEIVED AN RO1 GRANT FROM NIH FOR THE PROJECT, "MULTI-ETHNIC GWAS OF DIABETIC RETINOPATHY: ENHANCED POWER USING NEW METHODS." MASS. EYE AND EAR RESEARCH FELLOW IN OPHTHALMOLOGY, ARIEL WEINBERGER, PHD RECEIVED A F32 FELLOWSHIP AWARD GRANT FROM THE NIH FOR HER PROJECT ENTITLED, "THE EVOLUTIONARY DYNAMICS OF PLASMID UPTAKE IN PATHOGENIC BACTERIA." JANEY WIGGS, MD, PHD RECEIVED AN R01GRANT FROM THE NATIONAL EYE INSTITUTE FOR HER PROJECT ENTITLED, "THE NEIGHBORHOOD: POAG HERITABLE OVERALL OPERATIONAL DATABASE." RESEARCH TO PREVENT BLINDNESS HAS AWARDED A GRANT OF $110,000 TO THE MASS. EYE AND EAR TO SUPPORT RESEARCH INTO THE CAUSES, TREATMENT AND PREVENTION OF BLINDING DISEASES. THE RESEARCH WILL BE DIRECTED BY JOAN W. MILLER, MD, FARVO. FOR THE THIRD YEAR IN A ROW, AN APPLICATION TO SUPPORT THE ALCON RESEARCH SCHOLAR POSITION HAS BEEN APPROVED TO SUPPORT THE WORK OF A CLINICAL/TRANSLATIONAL RESEARCH FELLOW IN THE MASS. EYE AND EAR CORNEA SERVICE. THE GRANT IS ADMINISTERED BY REZA DANA, MD, MPH, MSC. MASS. EYE AND EAR CURING KIDS FUND HAS AWARDED GRANTS TO THREE MASS. EYE AND EAR OPHTHALMOLOGY FACULTY, INCLUDING: ERIC PIERCE, MD, PHD (DISEASE GENE DISCOVERY FOR LEBER CONGENITAL AMAUROSIS); DONG FENG CHEN, MD, PHD (EPIGENETIC REGULATION OF CONGENITAL RETINAL DYSTROPHY); AND BRUCE R. KSANDER, PHD (A NEW TREATMENT TO PREVENT THE DEVELOPMENT OF DRUG RESISTANT CANCER STEM CELLS IN RETINOBLASTOMA). CLINICAL TRIAL AWARDS THE DEPARTMENT'S CLINICAL RESEARCH EFFORTS CONTINUE STRONG GROWTH. BETWEEN MARCH 2012 AND OCTOBER 2012 THE DEPARTMENT EXPERIENCED A 23 PERCENT INCREASE IN CLINICAL RESEARCH STUDIES, FROM 132 TO 162. CLINICAL TRIALS (NIH DEFINITION) INCREASED AS WELL DURING THE SAME TIME PERIOD, FROM 29 TO 37. OTOLARYNGOLOGY: RESEARCH SUCCESSES: - RAMON A. FRANCO, JR., M.D., WILL LEAD A MULTI-NATIONAL RESEARCH COLLABORATION TO STUDY THROAT LESIONS THAT CAN LEAD TO CANCER. WORKING IN CONJUNCTION WITH SEVERAL EUROPEAN NATIONS, THE RESEARCH WILL USE THE DNA, RNA AND PROTEIN CHANGES SEEN IN A PATIENT'S BIOPSY SAMPLE AND DEVELOP A DATABASE OF INFORMATION THAT COULD HELP TO PROVIDE MORE INDIVIDUALIZED CARE. THIS PROJECT IS FUNDED BY A GRANT FROM MASSACHUSETTS LIFE SCIENCES CENTER. - IN COLLABORATION WITH SEOK-HYUN YUN, PH.D., FROM THE WELLMAN CENTER FOR PHOTOMEDICINE AT MASSACHUSETTS GENERAL HOSPITAL, JEFFREY TAO CHENG, PH.D., IS DEVELOPING A PROBE THAT CAN BE APPLIED TO OPTICAL COHERENCE TOMOGRAPHY (OCT) FOR A REVOLUTIONARY NONINVASIVE DIAGNOSTIC TOOL FOR MIDDLE EAR DISEASE. - A FEW YEARS AGO, SHARON G. KUJAWA, PH.D. AND M. CHARLES LIBERMAN, PH.D. DISCOVERED THAT OVEREXPOSURE TO MODERATE LEVELS OF NOISE CAN CAUSE DEGENERATION OF COCHLEAR NERVE FIBERS, EVEN IF THE HEARING THRESHOLDS (AND COCHLEAR HAIR CELLS) COMPLETELY RECOVER. THIS YEAR, DRS. KUJAWA AND LIBERMAN, ALONG WITH GRADUATE STUDENT ADAM FURMAN, SHOWED THAT THIS DEGENERATION IS SELECTIVE FOR THE HIGH-THRESHOLD NEURONS THAT NORMALLY HELP US HEAR IN A NOISY ENVIRONMENT. WE THINK THIS HELPS EXPLAIN WHY HEARING-IN-NOISE ABILITY DETERIORATES IN THE AGING EAR. - THE LYNCH CENTER FOR LASER AND RECONSTRUCTIVE SURGERY HAS RECRUITED A RESEARCH FELLOW TO INVESTIGATE THE GENETIC ORIGIN OF VASCULAR MALFORMATION. - JAMES W. ROCCO, M.D., PH.D., HAS BEGUN RECRUITING PARTICIPANTS TO HIS NIH-FUNDED STUDY OF BIOMARKERS FOR PREDICTING OUTCOME IN OROPHARYNGEAL CANCER. WITH EDMUND MROZ, PH.D., HE HAS DEVELOPED A WAY TO USE DNA SEQUENCING OF TUMORS TO MEASURE DIFFERENCES AMONG CANCER CELLS WITHIN INDIVIDUAL TUMORS. THEIR WORK INDICATES THAT SUCH "INTRA-TUMOR HETEROGENEITY" CONTRIBUTES TO POOR OUTCOMES IN HEAD AND NECK CANCER. - KONSTANTINA STANKOVIC, M.D., PH.D., IN COLLABORATION WITH ANANTHA P. CHANDRAKASAN, PH.D. FROM THE MASSACHUSETTS INSTITUTE OF TECHNOLOGY, WAS THE FIRST TO HAVE EXTRACTED ENERGY FROM THE BIOLOGIC BATTERY IN THE INNER EAR TO POWER ELECTRONICS WITHOUT DAMAGING HEARING. THIS SETS THE STAGE FOR FUTURE AUTONOMOUS SENSING OF KEY MOLECULES IN THE INNER EAR AND ITS VICINITY TO ESTABLISH DIAGNOSIS AND GUIDE THERAPY. - KONSTANTINA STANKOVIC, M.D., PH.D., IN COLLABORATION WITH ECOLE POLYTECHNIQUE FEDERAL DE LAUSSSANE (EPFL) IN SWITZERLAND, WAS THE FIRST TO HAVE IMAGED CELLS INSIDE THE INNER EAR WITH HIGH RESOLUTION AND WITHOUT CONTRAST DYES USING TWO-PHOTON MICROSCOPY THROUGH THE ROUND WINDOW. THIS SETS THE STAGE FOR ULTIMATE COCHLEAR ENDOSCOPY IN HUMANS TO ESTABLISH CELLULAR DIAGNOSIS. |
| NEW RESEARCH GRANTS: |
|
- BERTRAND DELGUTTE, PH.D., WAS AWARDED A CURING KIDS FUND GRANT FROM MASSACHUSETTS EYE AND EAR INFIRMARY TO STUDY "RESTORING BINAURAL HEARING WITH COCHLEAR IMPLANTS IN EARLY-ONSET DEAFNESS," WHICH WILL STUDY WAYS THAT PERCEPTUAL TRAINING CAN HELP THE BRAIN TO LOCATE SOUNDS IN SUBJECTS WITH EARLY-ONSET DEAFNESS. RESULTS WILL EVENTUALLY LEAD TO NEW SOUND PROCESSORS AND REHABILITATION STRATEGIES FOR PEOPLE WITH BILATERAL COCHLEAR IMPLANTS. - FUXIN SHI, PH.D., WAS AWARDED A CURING KIDS FUND GRANT FROM MASSACHUSETTS EYE AND EAR INFIRMARY TO STUDY "EXPLOITING THE WNT SIGNALING PATHWAY FOR CURING DEAFNESS IN CHILDREN," WHICH WILL TEST THE FEASIBILITY OF CURING DEAFNESS IN CHILDREN VIA REGENERATION OF FUNCTIONING HAIR CELLS. - BENJAMIN S. BLEIER, M.D., RECEIVED TWO GRANT AWARDS THIS YEAR, ONE FROM THE AMERICAN RHINOLOGIC SOCIETY TO FUND HIS PROJECT TITLED "MDR1/P-GP OVEREXPRESSION AND NEGATIVE FEEDBACK INSENSIVITY IN CRSWNP," AND ANOTHER FROM THE MICHAEL J. FOX FOUNDATION FOR HIS PROJECT TITLED "NON-INVASIVE STRIATAL DELIVERY OF GLIAL DERIVED NEUROPATHIC FACTOR (GDNF)." - RAMON A. FRANCO, JR., M.D., RECEIVED A GRANT AWARD FROM THE MASSACHUSETTS LIFE SCIENCES CENTER FOR HIS PROJECT TITLED "BIOMOLECULAR ANALYSIS OF LARYNGEAL DYSPLASIA." - DANIEL J. LEE, M.D., F.A.C.S. AND ALBERT EDGE, PH.D., WERE AWARDED AN R21 AWARD FROM THE NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS FOR HIS PROJECT TITLED "DELIVERY OF CHANNEL RHODOSPIN FOR OPTOGENETIC CONTROL OF NEURONS IN THE COCHLEA." THE MAJOR GOAL OF THIS GRANT IS TO OPTIMIZE THE EXPRESSION OF CHR2 IN THE AUDITORY PERIPHERY USING BOTH DIRECT TRANSFECTION AND STEM-CELL MEDIATED APPROACHES. BOTH ANATOMIC STUDIES AND PHYSIOLOGIC CHARACTERIZATION OF LIGHT-ACTIVATED RESPONSES WILL BE PERFORMED. - RICHARD F. LEWIS, M.D., WAS AWARDED AN R01 GRANT FROM THE NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS FOR HIS PROJECT TITLED "VESTIBULAR MIGRAINE INVESTIGATED WITH PSYCHOPHYSICAL AND OCULOMOTOR TESTS." - FELIPE SANTOS, M.D., WAS AWARDED A GRANT FROM THE AMERICAN OTOLOGICAL SOCIETY, FOR HIS STUDY: "EPIGENETIC REGULATION OF HAIR CELL REGENERATION IN ZEBRAFISH." - JEFFREY TAO CHENG, PH.D., WAS AWARDED A HARVARD CATALYST PILOT GRANT FOR HIS PROJECT, "OCT FOR MIDDLE EAR DISEASE." - RUTH ANNE EATOCK, PH.D., RECEIVED AN R01 GRANT FROM NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS FOR HER PROJECT TITLED " SYNAPTIC PROCESSING IN THE VESTIBULAR SYSTEM." - BARBARA HERRMANN, PH.D., CCC-A, BEGAN A NEW CLINICAL STUDY OF INFANT EVOKED RESPONSES TO NEW STIMULI, FUNDED BY NATUS MEDICAL, INC. - M. CHARLES LIBERMAN, PH.D., AND SHARON G. KUJAWA, PH.D., WERE AWARDED A NEW 5-YEAR R01 GRANT FROM THE NIDCD TO CONTINUE THEIR STUDY OF THE ROLE OF NOISE- INDUCED COCHLEAR NEURONAL DEGENERATION IN THE DETERIORATION OF HEARING-IN-NOISE ABILITIES AND IN THE GENERATION OF TINNITUS. DR. LIBERMAN WAS ALSO AWARDED A NEW 2-YEAR R21 FROM THE NIDCD TO STUDY THE IDEA THAT NEONATAL THIAMINE DEFICIENCY CAUSES A SPECIAL TYPE OF SENSORINEURAL HEARING LOSS CALLED AUDITORY NEUROPATHY. - JENNIFER R. MELCHER, PH.D., WAS AWARDED A GRANT FROM THE TINNITUS RESEARCH CONSORTIUM TO FUND HER PROJECT: "TINNITUS, AUDITORY BRAINSTEM RESPONSE, AND CEREBRAL CORTICAL STRUCTURE." DR. MELCHER WAS ALSO AWARDED AN R21 GRANT THIS YEAR FOR HER PROJECT TITLED "SENSORIMOTOR GATING IN HUMANS WITH TINNITUS AND HYPERACUSIS." - DANIEL M. MERFELD, PH.D., M.S.E., WAS AWARDED A GRANT FROM THE NIH-NIDCD FOR HIS PROJECT TITLED, "INNOVATIVE METHODOLOGIES FOR MEASURING BEHAVIORAL VESTIBULAR THRESHOLDS." - JOHN ROSOWSKI, PH.D., WAS AWARDED AN R01 GRANT FROM NIH-NIDCD TITLED "MIDDLE-EAR MECHANICS IN NORMAL AND PATHOLOGICAL EARS. RADIOLOGY: RESEARCH SUCCESSES: - MARY BETH CUNNANE, MD, SERVED AS CLINICAL INVESTIGATOR, "ROLE OF NON-EPI DIFFUSION WEIGHTED IMAGING IN EVALUATION OF CHOLESTEATOMA", IN CONJUNCTION WITH PHILLIPS MRI SCIENTISTS, 2012. ANESTHESIOLOGY: RESEARCH SUCCESSES: - NEW CLINICAL TRIAL |
| PART III - PROGRAM SERVICE, LINE 4B |
|
EDUCATION OVERALL (SUMMARY FROM PRINTED ANNUAL REPORT TEXT): CLINICAL CARE AND RESEARCH ARE ONLY TWO PARTS OF OUR MISSION. WE ALSO TEACH TOMORROW'S LEADERS. MASS. EYE AND EAR CONTINUED ITS ROBUST RESIDENCY AND FELLOWSHIP PROGRAMS. WE HELD SUCCESSFUL MEETINGS TOO NUMEROUS TO LIST. AS A DEPARTURE FROM THE TRADITIONAL MODE OF TEACHING, THE MASS. EYE AND EAR CATARACT MASTER, A NEW AND HIGHLY INNOVATIVE, COMPUTER-BASED SIMULATION TOOL DESIGNED TO TEACH RESIDENTS PHACOEMULSIFICATION CATARACT SURGERY, WAS LAUNCHED IN THE SPRING AND IS NOW AVAILABLE TO OPHTHALMOLOGY RESIDENCY PROGRAMS AND THE OPHTHALMOLOGY COMMUNITY WORLDWIDE. NEARLY A DECADE IN THE MAKING, THE CATARACT MASTER WAS CO-DEVELOPED BY HARVARD MEDICAL SCHOOL RESIDENCY TRAINING PROGRAM DIRECTOR, DR. JOHN I. LOEWENSTEIN, DR. BONNIE AN HENDERSON, ADAM NEAMAN, PH.D., AND COLLEAGUES. MASS. EYE AND EAR LICENSED THE ENGLISH VERSION OF THE PROGRAM TO THE AMERICAN SOCIETY OF CATARACT AND REFRACTIVE SURGEONS FOR WORLDWIDE DISTRIBUTION OVER THE INTERNET. WE WELCOMED THREE NEW FACULTY PROFESSORS. RUTH ANNE EATOCK, PH.D., DR. CHRISTOPHER HARTNICK AND DANIEL MERFELD, PH.D., WERE ALL NAMED PROFESSOR OF OTOLARYNGOLOGY AT HARVARD MEDICAL SCHOOL. IN ADDITION, WE ANNOUNCED TWO NEW ENDOWED PROFESSORSHIPS: - MASS. EYE AND EAR ENDOWED THE HARVARD MEDICAL SCHOOL LEFFENFIELD CHAIR OTOLOGY AND LARYNGOLOGY AND APPOINTED DR. RICHARD GLIKLICH AS THE FIRST INCUMBENT. UPON HIS RETIREMENT, THE CHAIR WILL BECOME THE LAURIE AND RICH GLIKLICH PROFESSORSHIP. - MASS. EYE AND EAR ALSO ESTABLISHED THE STEVEN C. AND CARMELLA R. KLETJIAN ENDOWED CHAIR OF GLOBAL SURGERY AND THE OFFICE OF GLOBAL SURGERY. DR. MACK CHENEY WAS APPOINTED DIRECTOR AND FIRST INCUMBENT OF THIS CHAIR. OPHTHALMOLOGY: MASS. EYE AND EAR CATARACT MASTER - THE MASS. EYE AND EAR CATARACT MASTER, A NEW AND HIGHLY INNOVATIVE, COMPUTER-BASED SIMULATION TOOL DESIGNED TO TEACH RESIDENTS PHACOEMULSIFICATION CATARACT SURGERY, WAS LAUNCHED IN THE SPRING AND IS NOW AVAILABLE TO OPHTHALMOLOGY RESIDENCY PROGRAMS AND THE OPHTHALMOLOGY COMMUNITY WORLDWIDE. NEARLY A DECADE IN THE MAKING, THE CATARACT MASTER WAS CO-DEVELOPED BY HARVARD MEDICAL SCHOOL RESIDENCY TRAINING PROGRAM DIRECTOR, JOHN I. LOEWENSTEIN, MD, BONNIE AN HENDERSON, MD, FACS, ADAM NEAMAN, PHD, AND SEVERAL OF THEIR COLLEAGUES. THE CATARACT MASTER RECEIVED AN ENTHUSIASTIC RECEPTION DURING ITS OFFICIAL DEBUT AT THE AMERICAN SOCIETY OF CATARACT AND REFRACTIVE SURGERY (ASCRS) ANNUAL MEETING IN APRIL 2012. MASS. EYE AND EAR HAS LICENSED THE ENGLISH VERSION OF THE PROGRAM TO ASCRS FOR WORLDWIDE DISTRIBUTION OVER THE INTERNET. - SIMMONS LECTURESHIP WAS ESTABLISHED. THE LECTURESHIP GIVES FIRST PREFERENCE FOR GLAUCOMA OR GLAUCOMA-RELATED TOPICS. THE FIRST LECTURE WAS DELIVERED BY JOEL S. SCHUMAN, MD, FACS, PROFESSOR AND CHAIRMAN OF OPHTHALMOLOGY, AND PROFESSOR OF BIOENGINEERING AT THE UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE. DR. SCHUMAN IS A HIGHLY REGARDED CLINICIAN AND GLAUCOMA SPECIALIST. - THE 2ND INTERNATIONAL BIENNIAL SYMPOSIUM ON AMD (SEPTEMBER 21-22, 2012) LED BY COMMITTEE CO-CHAIRS: PATRICA A. D'AMORE, PHD, MBA; IVANA K. KIM, MD; AND JOAN W. MILLER, MD, FARVO FOLLOWED THE HIGHLY SUCCESSFUL PRECEDENT SET BY THE INAUGURAL 2010 SYMPOSIUM. A DIVERSE AND DISTINGUISHED GROUP OF CLINICIANS AND RESEARCHERS FROM AROUND THE WORLD ENGAGED IN STIMULATING AND OPEN-ENDED PANEL DISCUSSIONS ON A WIDE ARRAY OF AMD TOPICS THAT INCLUDED: RPE/BRUCH'S MEMBRANE/CHORIOCAPILLARIS, INFLAMMATION, LIPIDS/CARDIOVASCULAR DISEASE, IMAGING, ANGIOGENESIS BEYOND VEGF, NEUROPROTECTION/REGENERATION, DRUG DELIVERY, AND NEURODEGENERATIVE DISEASES. THE INTERACTIVE FORMAT AND LIVELY DISCUSSION AND DEBATE DREW KUDOS FROM THE.200+ CLINICIANS, RESEARCHERS, AND TRAINEES IN ATTENDANCE. - THE 27TH CORNEA BIENNIAL CONFERENCE (SEPTEMBER 30-OCTOBER 1, 2011), CO-HOSTED BY SCHEPENS EYE RESEARCH INSTITUTE AND THE MASS. EYE AND EAR, WITH SUPPORT FROM BOSTON UNIVERSITY SCHOOL OF MEDICINE, AND TUFTS UNIVERSITY CENTER FOR VISION RESEARCH FEATURED 29 DISTINGUISHED NATIONAL AND INTERNATIONAL SPEAKERS, AND RAISED OVER $100,000 FOR EYE RESEARCH. - IN MARCH 2012, ROBERT PINEDA II, MD AND SHERLEEN CHEN, MD, TRAVELED TO SHANGHAI, CHINA TO CONDUCT A COURSE IN ADVANCED SKILLS TO PHACOEMULSIFICATION CATARACT SURGEONS. THE "CHINA ALCON ADVANCED CATARACT COURSE," THE FIRST OF ITS KIND IN SHANGHAI, WAS UNDERTAKEN AS PART OF THE DEPARTMENT'S EDUCATIONAL PARTNERSHIP WITH SHANGHAI EYE AND ENT HOSPITAL. - FOR THE THIRD YEAR IN A ROW, WE HELD ANOTHER HIGHLY SUCCESSFUL MASS. EYE AND EAR INTENSIVE VITREORETINAL COURSE (JULY 20-21, 2012), A UNIQUE AND COMPREHENSIVE WORKSHOP COVERING THE THEORY AND PRACTICE OF VITREORETINAL SURGERY. FREE OF CHARGE TO PARTICIPANTS, THE COURSE IS DESIGNED EXCLUSIVELY FOR FIRST-YEAR VITREORETINAL FELLOWS TO PREPARE THEM FOR THE OR EXPERIENCE OF THE CLINICAL FELLOWSHIP. THIS EVENT CONTINUES TO DRAW A DISTINGUISHED CADRE OF EMINENT FACULTY FROM VARIOUS INSTITUTIONS WORLDWIDE. COURSE DIRECTORS ARE JOHN LOEWENSTEIN, MD, DEAN ELIOTT, MD, AND DEMETRIOS VAVVAS, MD, PHD. - THE 5TH MILITARY VISION SYMPOSIUM ON OCULAR & VISION INJURY HELD SEPTEMBER 18-20, 2012 FOCUSED ON MILITARY AND CIVILIAN OCULAR RESEARCH. THE SYMPOSIUM COVERED THE TOPICS OF COMBAT OCULAR READINESS, BLAST INJURY/BLAST EYE, OCULAR PAIN, INFLAMMATION AND INFECTION, TELEHEALTH, TELEPRESENCE & INFORMATICS, REGENERATIVE MEDICINE, AND VISION FUNDING. - DIGITAL JOURNAL OF OPHTHALMOLOGY WILL NOW BE INCLUDED IN PUBMED CENTRAL AND INDEXED IN THE NATIONAL LIBRARY OF MEDICINE'S MEDLINE DATABASE, WHICH SHOULD SIGNIFICANTLY INCREASE ITS PROFILE. |
| OTOLARYNGOLOGY: |
|
EDUCATIONAL HIGHLIGHTS: - UPCOMING CME COURSES - "UPDATE ON TRACHEO-ESOPHAGEAL VOICE RESTORATION AND LARYNGECTOMY CARE," DIRECTED BY DANIEL G. DESCHLER, M.D., F.A.C.S., AND GLENN BUNTING, M.S. - MARCH 15-16, 2013, MASSACHUSETTS EYE AND EAR INFIRMARY. - "LARYNGOLOGY DISORDERS UPDATE," DIRECTED BY RAMON A. FRANCO, JR., M.D., AND PHILLIP SONG, M.D. - MAY 9-10, 2013, MASSACHUSETTS EYE AND EAR INFIRMARY. - PLANNED OTOLOGY COURSE - JUNE 7-8, 2013, MASSACHUSETTS EYE AND EAR INFIRMARY - "12TH INTERNATIONAL FACIAL NERVE SYMPOSIUM," DIRECTED BY TESSA A. HADLOCK, M.D., MACK L. CHENEY, M.D., AND MICHAEL J. MCKENNA, M.D. - JUNE 28-JULY 2, 2013, LIBERTY HOTEL. - THE DEPARTMENT IS CURRENTLY AT WORK IN CONSTRUCTING AN ENT SURGICAL TRAINING LABORATORY AT MASSACHUSETTS EYE AND EAR INFIRMARY THAT IS SET TO OPEN IN JANUARY 2013. THE ENT SURGICAL TRAINING LABORATORY WILL ADVANCE INSTRUCTION CAPABILITIES IN NEARLY EVERY SUB-SPECIALTY OF OTOLARYNGOLOGY, INCLUDING: SKULL BASE SURGERY, GENERAL OTOLARYNGOLOGY, HEAD AND NECK SURGERY, LASER SURGERY, OTOLOGY AND NEUROTOLOGY, FACIAL PLASTIC AND RECONSTRUCTIVE SURGERY, SINUS SURGERY, LARYNGOLOGY, AND PEDIATRIC OTOLARYNGOLOGY. RESIDENTS AND FELLOWS, AS WELL AS EXPERIENCES SURGEONS PREPARING FOR COMPLEX CASES, WILL BENEFIT FROM THE LABORATORY AS A RESOURCE. - NICOLAS Y. BUSABA, M.D., F.A.C.S., LEADS A TEACHING INITIATIVE WITH THE MINISTRY OF HEALTH IN KUWAIT FOR A FIVE-YEAR COLLABORATION WITH THE DEPARTMENT OF OTOLARYNGOLOGY AT THE MASSACHUSETTS EYE AND EAR INFIRMARY. - GREGORY W. RANDOLPH, M.D., F.A.C.S., COMPLETED A SECOND EDITION OF SURGERY OF THE THYROID AND PARATHYROID GLANDS, PUBLISHED BY SAUNDERS/ELSEVIER. THE TEXT WAS NAMED SAUNDERS/ELSEVIER BEST-SELLING BOOK AT THE ANNUAL AAO MEETING IN WASHINGTON, D.C. RADIOLOGY: EDUCATIONAL HIGHLIGHTS: - GUL MOONIS, MD, MARY BETH CUNNANE, MD, AND HUGH D. CURTIN, MD, PUBLISHED AN ARTICLE ENTITLED "PATTERNS OF PERINEURAL TUMOR SPREAD IN HEAD AND NECK CANCER". MAGN RESON IMAGING CLIN N AM. 2012 AUG;20(3):435-6 - MARY BETH CUNNANE, MD, ET AL PUBLISHED AN ARTICLE ENTITLED "CASE RECORDS OF THE MASSACHUSETT GENERAL HOSPITAL, CASE 29-2012-A 49 YEAR-OLD MAN WITH PAIN AND CRANIAL-NERVE PALSIES AFTER TREATMENT OF ORAL CANCER". N ENGL J MED. 2012 SEP 20;367(12):1136-47. - MARY BETH CUNNANE, MD, AND AMY JULIANO, MD, PUBLISHED AN ARTICLE ENTITLED "BENIGN CONDITIONS OF THE THYROID GLAND". SEMIN ULTRASOUND CT MR. 2012 APR;33(2):130-7. - MARY BETH CUNNANE, MD, ET AL PUBLISHED AN ARTICLE ENTITLED "COLOR DOPPLER ULTRASOUND: EFFECTIVE MONITORING OF THE BURIED FREE FLAP IN FACIAL REANIMATION". OTOLARYNGOL HEAD NECK SURG. 2012 MAR;146(3):372-6. - GUL MOONIS, MD, ET AL PUBLISHED AN ARTICLE ENTITLED "SUPERIOR SEMICIRCULAR CANAL DEHISCENCE IN EAST ASIAN WOMEN WITH OSTEOPOROSIS". BMC EAR NOSE THROAT DISORD. 2012 JUL 25;12(1):8. - GUL MOONIS, MD, ET AL PUBLISHED AN ARTICLE ENTITLED "MULTIMODALITY IMAGING OF HYDROGEL SCLERAL BUCKLES". RETINA. 2012 SEP;32(8):1449-52. - LAURA ROMO, MD, ET AL PUBLISHED AN ARTICLE ENTITLED "TAMPON USE IN ADOLESCENCE: DIFFERENCES AMONG EUROPEAN AMERICAN, AFRICAN AMERICAN AND LATINA WOMEN IN PRACTICES, CONCERNS AND BARRIERS". J PEDIATR ADOLESC GYNECOL. 2012 OCT;25(5):328-33. - PAUL CARUSO, MD, ET AL PUBLISHED AN ARTICLE ENTITLED "RISK OF SECOND CANCERS AFTER PHOTON AND PROTON RADIOTHERAPY: A REVIEW OF THE DATA". HEALTH PHYS. 2012 NOV;103(5):577-85. - PAUL CARUSO, MD, ET AL PUBLISHED AN ARTICLE ENTITLED "HYPOPERFUSION PREDICTS LESION PROGRESSION IN CEREBRAL X-LINKED ADRENOLEUKODYSTROPHY". BRAIN. 2012 SEP;135(PT9):2676-83. - HUGH D. CURTIN, MD, MARY BETH CUNNANE, MD, AND AMY JULIANO, MD, PRESENTED MULTIPLE LECTURES AT MRI & CT COURSES THAT WERE HELD WITHIN THE YEAR. ANESTHESIOLOGY: PUBLICATIONS, LECTURES, COURSES - JOSEPH BAYES, MD ANESTHESIOLOGY 2ND EDITION 2012 ED. LONGNECKER DE ET AL. "ANESTHESIA FOR OPHTHALMIC SURGERY" BAYES J, BASTA S. PP 1206-1225. - BIL RAGAN, MD ANESTHESIOLOGY 2ND EDITION 2012 ED. LONGNECKER DE ET AL. "ANESTHESIA FOR OTORHINOLARYNGOLOGIC (ENT) SURGERY" RAGAN B. PP 1226-1247. |
| PART III - PROGRAM SERVICE, LINE 4C |
|
PATIENT CARE OVERALL (FROM THE PRINTED ANNUAL REPORT TEXT): CHANGING LIVES IS WHAT MASS. EYE AND EAR IS ALL ABOUT. OUR DOCTORS, NURSES, AND OTHER CAREGIVERS STRIVE DAILY TO PROVIDE SOLUTIONS FOR COMPLEX MEDICAL ISSUES THAT AFFECT PATIENTS. THE NEW MASS. EYE AND EAR, LONGWOOD, A 90,000 SQUARE FOOT OUTPATIENT AND AMBULATORY SURGICAL CENTER, IS NOW OPEN AT 800 HUNTINGTON AVENUE, BOSTON. BUILT FROM THE GROUND UP IN JUST 12 MONTHS, THIS CENTER ACTUALLY REPRESENTS SEVERAL YEARS OF INTENSE PLANNING. IT IS HOME TO FOUR OPERATING ROOMS AND A STATE-OF-THE-ART SURGICAL CENTER FOR EYE AND ENT PATIENTS, WHICH IS STAFFED BY AN OUTSTANDING MASS. EYE AND EAR ANESTHESIA AND NURSING TEAM. MASS. EYE AND EAR, LONGWOOD IS ALSO HOME TO AN EXPANDED DEPARTMENT OF OPHTHALMOLOGY, WHOSE PHYSICIANS COMPRISE THE EYE SERVICE FOR BRIGHAM AND WOMEN'S HOSPITAL. EYE SERVICES, LOCATED ON THE CENTER'S THIRD FLOOR, INCLUDE ROUTINE CARE, AS WELL AS COMPREHENSIVE EVALUATION AND TREATMENT OF COMPLEX AND SYSTEMIC DISORDERS SUCH AS CATARACTS, DIABETIC RETINOPATHY, GLAUCOMA, MACULAR DEGENERATION, RETINAL DETACHMENT, AND OPHTHALMIC PLASTIC SURGERY. ADDITIONALLY, THE CENTER OFFERS REFRACTIVE SURGERY EVALUATIONS, OPTOMETRY AND CONTACT LENS CARE AND A FULL-SERVICE OPTICAL SHOP. ADDITIONALLY, THE THIRD FLOOR WILL SERVE AS ONE OF TWO HOMES FOR THE MASS. EYE AND EAR COLLABORATION WITH JOSLIN DIABETES CENTER/BEETHAM EYE INSTITUTE. AS PART OF AN INTEGRATED APPROACH, MASS. EYE AND EAR AND JOSLIN HAVE COMBINED FORCES TO TREAT DIABETIC PATIENTS WITH EYE DISEASE. TOGETHER, THEY SEE PATIENTS AT 800 HUNTINGTON AND AT THE BEETHAM EYE CLINIC, 1 JOSLIN PLACE. MASS. EYE AND EAR, LONGWOOD HAS A FULL-SERVICE PARKING GARAGE, ACCESSIBLE FROM FRAWLEY STREET WITH SELF-PARKING AND VALET PARKING AVAILABLE. THE NEW CENTER IS ALSO EASY TO REACH BY GREEN LINE OR BUS, AND IS JUST A FIVE MINUTE WALK FROM BRIGHAM AND WOMEN'S HOSPITAL. THE NEW CENTER IN LONGWOOD IS JUST ONE PART OF A BROADER STRATEGY TO MAKE MASS. EYE AND EAR CARE MORE ACCESSIBLE AND CONVENIENT TO PATIENTS. IN FIVE YEARS, THE NUMBER OF LOCATIONS FOR MASS. EYE AND EAR EYE AND ENT SERVICES HAS GROWN FROM FOUR TO 13! ADDITIONS INCLUDE A BRAND NEW CLINICAL CARE SITE IN CONCORD, WHERE WE HAVE WELCOMED DR. MICHAEL FATTAL TO THE ENT STAFF. ALSO LAST YEAR, WE OPENED A ROBUST RETINA PRACTICE ON WOODLAND ROAD IN STONEHAM; AND MASS. EYE AND EAR SOUTH, WITH MULTIPLE LOCATIONS IN QUINCY, WEYMOUTH, DUXBURY AND EAST BRIDGEWATER CONTINUES TO THRIVE. ON OUR MAIN CAMPUS, WE HAVE COMPLETED SEVERAL RENOVATIONS TO CLINICAL SPACE, AS PART OF AN ONGOING EFFORT TO BETTER SERVE PATIENTS. SOME OF THESE IMPROVEMENTS INCLUDE THE EYE CLINICS ON THE 1ST FLOOR; A NEW SINUS CENTER ON THE 9TH FLOOR; AND A NEW NEURO-OPHTHALMOLOGY SUITE ON THE 9TH FLOOR. SEVERAL RESEARCH LABS, BOTH IN THE MAIN BUILDING AND AT SCHEPENS EYE RESEARCH INSTITUTE, HAVE ALSO UNDERGONE EXTENSIVE RENOVATION. - MASSACHUSETTS EYE AND EAR INFIRMARY CONTINUES ITS COMMITMENT TO DELIVERING EXCELLENCE IN CLINICAL CARE, RESEARCH AND TEACHING WITH THE UNIFIED GOAL OF ADVANCING THE CARE WE PROVIDE TO OUR PATIENTS. - ONCE AGAIN, MASS. EYE AND EAR RANKS AS A TOP SPECIALTY HOSPITAL NATIONWIDE, ACCORDING TO THE 2012-2013 U.S. NEWS & WORLD REPORT "BEST HOSPITALS" SURVEY. MASS. EYE AND EAR OPHTHALMOLOGY IS LISTED #4 NATIONALLY. MASS. EYE AND EAR OTOLARYNGOLOGY RANKED #3 IN THE NATION. BOTH ASSISTED MGH IN ATTAINING THE #1 SPOT IN THE NATION. - HIGHEST QUALITY CARE AS OUR LOCATIONS INCREASED THIS YEAR, SO GREW OUR MEDICAL STAFF. WE ADDED A CADRE OF HOSPITAL-BASED PHYSICIANS TO MEET THE DEMAND OF INCREASED VOLUME IN BOTH THE OPERATING ROOMS AND THE CLINICS. - MASS. EYE AND EAR WELCOMED TERESA BEAN, M.D., ANESTHESIOLOGY; MARK BERNARDO, O.D., LONGWOOD, OPTOMETRY; KATHRIN BOURDEAU, M.D., ANESTHESIOLOGY; JASON COMANDER, M.D., PH.D., RETINA/ERG SERVICE; JAYME DOWDALL, M.D., LARYNGOLOGY; DANIEL ESMAILI, M.D., RETINA SERVICE; MICHAEL FATTAL, M.D., CONCORD, OTOLARYNGOLOGY; AMIR GHOLAMI, M.D., ANESTHESIOLOGY; HILARY KELLY, M.D., RADIOLOGY; DANIEL LEFEBVRE, M.D., OPHTHALMIC PLASTIC/RECONSTRUCTIVE; MONICA LEE, M.D., WEYMOUTH-DUXBURY OTOLARYNGOLOGY; ROBIN LINDSAY, M.D., FACIAL PLASTIC/RECONSTRUCTIVE SURGERY; ZHONGHUI KATIE LUO, M.D., PH.D., COMPREHENSIVE OPHTHALMOLOGY; BENJAMIN MIZELL, M.D., ANESTHESIOLOGY; ALICIA QUESNEL, M.D., OTOLARYNGOLOGY; NITA SAHANI, M.D., ANESTHESIOLOGY; AND DAVID WU, M.D., PH.D., RETINA. - ALL OF MASS. EYE AND EAR'S MEDICAL PROFESSIONALS, WHETHER NEW TO THE STAFF OR WELL-SEASONED, ARE DEDICATED TO PROVIDING PATIENTS WITH THE BEST OUTCOMES AND THE MOST COMPASSIONATE CARE. TO MEASURE THEIR SUCCESS, MASS. EYE AND EAR PUBLISHED ITS SECOND OUTCOMES BOOK FOR OPHTHALMOLOGY AND OTOLARYNGOLOGY. WE CONTINUED OUR SUCCESSFUL SCHWARTZ CENTER COMPASSIONATE CARE ROUNDS WITH STANDING-ROOM-ONLY PARTICIPATION FROM DOCTORS, NURSES, SOCIAL WORKERS AND ADMINISTRATIVE STAFF. THESE EFFORTS HAVE PAID OFF. ONCE AGAIN MASS. EYE AND EAR WAS RECOGNIZED FOR ITS CLINICAL EXCELLENCE IN U.S. NEWS & WORLD REPORT'S "BEST HOSPITALS" SURVEY (THIRD IN OTOLARYNGOLOGY AND FOURTH IN OPHTHALMOLOGY). OPHTHALMOLOGY: NEW SERVICES OPENED: MASS. EYE AND EAR, LONGWOOD - THE NEW MASS. EYE AND EAR MULTI-SPECIALTY AMBULATORY CARE CENTER AT 800 HUNTINGTON AVE OFFICIALLY OPENED OCTOBER 31, 2012. THE LOCATION WILL PROVIDE THE LONGWOOD/MISSION HILL NEIGHBORHOODS GREATER ACCESS TO MASS. EYE AND EAR'S WORLD-CLASS PHYSICIANS AND SURGEONS, AND OUTPATIENT SERVICES. THE FACILITY IS EXPECTED TO BEGIN ACCEPTING PATIENTS IN NOVEMBER. COMPREHENSIVE AND SUBSPECIALTY SERVICES IN RETINA, CORNEA, GLAUCOMA, EYE PLASTICS AND UVEITIS WILL BE AVAILABLE, AND THE SITE WILL BE FULLY EQUIPPED FOR SURGERY, PROCEDURES, IMAGING AND DIAGNOSTICS. MASS. EYE AND EAR WILL CONTINUE TO PROVIDE INPATIENT AND EMERGENCY EYE TRAUMA CARE AT AFFILIATED HOSPITALS. PARTICIPATING MASS. EYE AND EAR FACULTY INCLUDE: CAROLYN KLOEK (MEDICAL DIRECTOR), MD, JOHN LOEWENSTEIN, MD, SHEILA BORBOLI-GEROGIANNIS, MD, FACS, DANIEL LEFEBVRE, MD, ANN-MARIE LOBO, MD, ZHONGHUI KATIE LUO, MD, PHD, DAVID WU, MD, PHD, LUCY SHEN, MD, AND MARK BERNARDO, OD. SEVERAL OPEN HOUSES WILL BE HELD OVER THE NEXT FEW MONTHS TO INTRODUCE THE FACILITY AND STAFF TO THE NEIGHBORING HOSPITAL AND REFERRAL COMMUNITY. |
| MASS. EYE AND EAR RETINA CONSULTANTS, STONEHAM |
|
- IN JANUARY, MASS. EYE AND EAR ACQUIRED A LARGE RETINA PRACTICE AT 3 WOODLAND ROAD IN STONEHAM WHERE IT OPENED A NEW SATELLITE OFFICE, RETINA CONSULTANTS. THE NEW PRACTICE OFFERS SUBSPECIALTY MEDICAL AND SURGICAL CARE FOR MACULAR DEGENERATION, DIABETIC EYE AND ALL CONDITIONS ASSOCIATED WITH THE RETINA. THE NEW PRACTICE EXPANDS THE DEPARTMENT'S REACH IN A SUBURBAN AREA AND MAKES RETINA SERVICES MORE ACCESSIBLE TO PATIENTS. THE SERVICE IS DIRECTED BY DANIEL ESMAILI, MD, WITH PARTICIPATION FROM SEVERAL RETINA PHYSICIANS, INCLUDING: DEAN ELIOTT, MD; LEO KIM, MD, PHD; JOAN W. MILLER, MD, FARVO; AND LUCY YOUNG, MD, PHD. MASS. EYE AND EAR AND JOSLIN DIABETES CENTER FORM CLINICAL AND RESEARCH ALLIANCE - UNDER THE DIRECTION OF LLOYD PAUL AIELLO, MD, PHD, ASSOCIATE CHIEF FOR LONGWOOD, THIS NOVEL NEW PARTNERSHIP WILL PROVIDE A FULL ARRAY OF HIGH QUALITY, COMPREHENSIVE AND SUBSPECIALTY EYE CARE TO OPHTHALMOLOGY PATIENTS, ESPECIALLY TO THOSE WHO ARE AT-RISK FOR DIABETES-RELATED EYE COMPLICATIONS. CLINICAL OFFICES WILL BE CO-LOCATED AT ONE JOSLIN PLACE AND MASS. EYE AND EAR'S NEW AMBULATORY CARE CENTER AT 800 HUNTINGTON AVENUE. COMBINING THE EXPERTISE AND RESOURCES OF THESE INSTITUTIONS WILL ALLOW US TO PROVIDE HIGH QUALITY AND COST-EFFECTIVE CARE WHILE MAKING OUR SERVICES MORE CONVENIENT AND ACCESSIBLE TO MORE PATIENTS. STRENGTHENING OUR RESEARCH COLLABORATIONS WILL MORE RAPIDLY ADVANCE OUR SHARED GOAL OF ERADICATING EYE DISEASE. NEW RECRUITS: CLINICIANS AND CLINICIAN SCIENTISTS - JASON COMANDER, MD, PHD, MASS. EYE AND EAR, RETINA AND ELECTRORETINOGRAPHY SERVICES - DANIEL ESMAILI, MD, MASS. EYE AND EAR, RETINA SERVICE - DANIEL LEFEBVRE, MD, MASS. EYE AND EAR, OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY SERVICE - ZHONGHUI KATIE LUO, MD, PHD, MASS. EYE AND EAR, COMPREHENSIVE OPHTHALMOLOGY SERVICE - DAVID WU, MD, PHD, MASS EYE AND EAR, RETINA SERVICE - MARK BERNARDO, OD, MASS. EYE AND EAR, OPTOMETRY NEW EQUIPMENT AND TECHNOLOGY: CLINICAL - VERIS MULTI-FOCAL ERG FOR THE 3RD FLOOR - VERIS MULTI-FOCAL ERG FOR THE 12TH FLOOR - CIRRIUS OCT MACHINE FOR THE RETINA SERVICE - VU MAX ULTRASOUND UNIT - A SCAN B SCAN UBM - SONOMED ESCALON LENSTAR FOR THE CORNEA SERVICE - 2 OPTOS WIDE ANGLE CAMERAS FOR THE RETINA SERVICE - SPECTRUM MICROSCOPE FOR THE MASS. EYE AND EAR RETINA ASSOCIATES IN STONEHAM NEW SERVICES/RENOVATIONS MASS. EYE AND EAR, LONGWOOD MASS. EYE AND EAR RETINA ASSOCIATES, STONEHAM IN APRIL (2012), THE GLAUCOMA SERVICE MOVED INTO ITS NEWLY RENOVATED CLINICAL SPACE ON THE FIRST FLOOR OF THE MAIN BUILDING. COMMUNITY SERVICE ACTIVITIES LOCAL/REGIONAL - NEIGHBORHOOD CHARTER SCHOOL (17TH) YEAR - PROVIDED VISION SCREENINGS TO 500 CHILDREN. - CAMP HARBOR VIEW, LONG ISLAND, MA (17TH YEAR) - EYE SCREENINGS FOR 149 CAMPERS, AGES 11-14, FROM UNDERSERVED BOSTON NEIGHBORHOODS. - MASS. EYE AND EAR PARTNERED WITH VISION COALITION MA TO PROVIDE VISION EXAMS TO STUDENTS IN THE YEAR UP, BOSTON PROGRAM. - BOOMERS AND SENIORS EXPO AT THE SEAPORT WORLD TRADE CENTER: SHELIA BORBOLI, MD, COMPREHENSIVE OPHTHALMOLOGY SERVICE, PRESENTED "CATARACTS AND BABY BOOMERS." - A GRAVES DISEASE AND THYROID EYE DISEASE SUPPORT GROUP WAS HELD QUARTERLY BY THE OPHTHALMIC PLASTIC SURGERY. - THERESA CHEN, MD, MEDICAL DIRECTOR, OPHTHALMOLOGY QUALITY AND OUTCOMES VOLUNTEERED ON THE LIONS EYE VAN PROVIDING FREE EYE SCREENINGS. - MARK BERNARDO, OD, OF THE MASS. EYE AND EAR OPTOMETRY SERVICE SERVED WITH VOLUNTEER OPTOMETRIC SERVICES TO HUMANITY. - LUCIA SOBRIN, MD, MPH, ASSISTANT PROFESSOR OF OPHTHALMOLOGY AT HMS, WAS A FEATURED GUEST SPEAKER IN JANUARY FOR THE ARTSEMERSON ONE-WOMAN SHOW, "SUGAR," STARRING EMERSON COLLEGE PERFORMING ARTS PROFESSOR AND INTERNATIONALLY ACCLAIMED PERFORMANCE ARTIST ROBBIE MCCAULEY. "SUGAR," EXAMINES THE STRUGGLES AND CONQUESTS OF LIVING WITH "A LITTLE BIT OF SUGAR": DIABETES. A CENTRAL THEME OF THE SHOW WAS TO REFLECT ON DIABETES FROM THE AFRICAN AMERICAN PERSPECTIVE AS THIS DISEASE DISPROPORTIONATELY AFFECTS PEOPLE OF COLOR. AS THE FEATURED GUEST, DR. SOBRIN PARTICIPATED IN A "TALK BACK" SESSION ALONG WITH MS. MCCAULEY AFTER ONE OF THE PERFORMANCES AND DISCUSSED HER PROMISING RESEARCH ON DIABETIC RETINOPATHY THAT MAY ONE DAY LEAD TO CURES TO THIS DISEASE. - ON BEHALF OF THE GLAUCOMA FOUNDATION, LOUIS PASQUALE, MD, DIRECTOR, GLAUCOMA SERVICE AND DIRECTOR, TELEMEDICINE LED A TELECONFERENCE FOR LAY PEOPLE REGARDING LIFESTYLE ISSUES IN GLAUCOMA. OTOLARYNGOLOGY: - IN 2012 THE DEPARTMENT EXPANDED BY RECRUITING FIVE NEW FULL-TIME PHYSICIANS, INCLUDING THREE AT THE MAIN CAMPUS AND TWO AT OUR SUBURBAN CENTERS. ADDITIONALLY, WE NOW OFFER COMPREHENSIVE LASER AND RECONSTRUCTIVE SURGERY AT THE CAROLYN AND PETER LYNCH CENTER FOR LASER AND RECONSTRUCTIVE SURGERY, DEDICATED ON MAY 29, 2012, AND A MULTI-DISCIPLINARY SLEEP CENTER AT MASS. EYE AND EAR, QUINCY. TWO OF OUR PHYSICIANS NOW PROVIDE ADVANCED ROBOTIC SURGERY FOR PATIENTS SUFFERING FROM HEAD AND NECK CANCER. NEW RECRUITS: - JAYME R. DOWDALL, M.D., DIVISION OF LARYNGOLOGY, INSTRUCTOR OF OTOLOGY AND LARYNGOLOGY, HARVARD MEDICAL SCHOOL - MICHAEL H. FATTAL, M.D., MASS. EYE AND EAR, CONCORD, CLINICAL INSTRUCTOR OF OTOLOGY AND LARYNGOLOGY, HARVARD MEDICAL SCHOOL - MONICA S. LEE, M.D., MASS. EYE AND EAR, WEYMOUTH-DUXBURY, CLINICAL INSTRUCTOR OF OTOLOGY AND LARYNGOLOGY, HARVARD MEDICAL SCHOOL - ROBIN W. LINDSAY, M.D., DIVISION OF FACIAL PLASTIC AND RECONSTRUCTIVE SURGERY, ASSISTANT PROFESSOR OF OTOLOGY AND LARYNGOLOGY, HARVARD MEDICAL SCHOOL - ALICIA M. QUESNEL, M.D., DIVISION OF OTOLOGY, INSTRUCTOR OF OTOLOGY AND LARYNGOLOGY, HARVARD MEDICAL SCHOOL NEW EQUIPMENT/TECHNOLOGY: - WITH THE NEW LYNCH CENTER FOR LASER AND RECONSTRUCTIVE SURGERY, DEDICATED ON MAY 29, 2012, WE NOW OFFER STATE-OF-THE-ART LASER EQUIPMENT FOR THE WIDEST RANGE OF SKIN TREATMENTS. - A MULTI-DISCIPLINARY SLEEP CENTER WAS RECENTLY OPENED AT MASS. EYE AND EAR, QUINCY, TO PROVIDE COMPREHENSIVE SLEEP STUDIES AND TREATMENT FOR PATIENTS WHO MAY SUFFER FROM OBSTRUCTIVE SLEEP APNEA, SNORING, INSOMNIA, NARCOLEPSY, OR RESTLESS LEG SYNDROME. - FOR TREATING PATIENTS WITH HEAD AND NECK CANCER, JAMES W. ROCCO, M.D., PH.D. IS WORKING WITH DERRICK T. LIN, M.D., F.A.C.S., TO OFFER ROBOTIC SURGERY FOR MASSACHUSETTS EYE AND EAR INFIRMARY PATIENTS, USING TECHNOLOGY AVAILABLE AT WINCHESTER HOSPITAL. NEW SERVICES/RENOVATIONS: - LASER AND RECONSTRUCTIVE SURGERY - THE SINUS CENTER |
| - MASS. EYE AND EAR, QUINCY SLEEP CENTER |
|
- THE HEAD AND NECK SURGICAL ONCOLOGY DIVISION HOSTED A FREE ORAL, HEAD, AND NECK CANCER SCREENING TO THE PUBLIC AT OUR BOSTON LOCATION, AS WELL AS THE MASS. EYE AND EAR SOUTH LOCATIONS IN QUINCY, MILTON, AND WEYMOUTH, ON APRIL 20TH, 2012. - IN COLLABORATION WITH THE AMERICAN ACADEMY OF DERMATOLOGY, DRS. JESSICA FEWKES AND OON TIAN TAN PROVIDED FREE SKIN CANCER SCREENINGS TO THE PUBLIC ON MAY 15TH, 2012. - THE FACIAL PLASTIC AND RECONSTRUCTIVE SURGERY DIVISION, LED BY TESSA A. HADLOCK, M.D., WENT ON A MISSION TO QUITO, ECUADOR IN MARCH 2012 AND ANOTHER TO ANTIGUA, GUATEMALA IN JULY 2012. DR. TAN WAS INSTRUMENTAL IN INSTALLING A CANDELA/SYNERON ALEXANDRITE LASER AT THE INSTITUTO MEDICO TIERRA NUEVA, QUITO FOR LASER HAIR REMOVAL IN MICROTIA PATIENTS. THE LASER WAS FUNDED BY AN AWARD FROM THE MASSACHUSETTS EYE AND EAR INFIRMARY "CURING KIDS FUND". - THE FACIAL PLASTIC AND RECONSTRUCTIVE SURGERY DIVISION ALSO CONTINUES THEIR COLLABORATION WITH THE ROSE FUND, OFFERING RECONSTRUCTIVE SURGERY TO VICTIMS OF DOMESTIC VIOLENCE. - GREGORY W. RANDOLPH, M.D., F.A.C.S., LED A SURGICAL GOITER MISSION TO MIGORI, KENYA THROUGH THE KENYA RELEIF AFRICAN AID ORGANIZATION. OTHER MEMBERS OF THE TEAM ARE DR. PAUL KONOWITZ, DR. GREGORY RANDOLPH, DR. DAVID LESNIK, RESIDENT DR. DUNIA ABDUL-AZIZ AND NANCY KOTZUBA, R.N. THE TEAM PERFORMED 25 THYROID SURGERY CASES IN 3 DAYS, INCLUDING 18 GOITERS. - OPERATION AIRWAY IS A NON-PROFIT INITIATIVE DIRECTED BY CHRISTOPHER J. HARTNICK, M.D. OPERATION AIRWAY PROVIDES ANNUAL MEDICAL MISSIONS TO ECUADOR TO HELP CARE FOR CHILDREN WITH AIRWAY DISORDERS. A TEAM OF SURGEONS, ANESTHESIOLOGISTS, PEDIATRIC NURSES, AND ICU PHYSICIANS FROM THE MASS. GENERAL HOSPITAL FOR CHILDREN PROVIDE NEEDED MEDICAL CARE WHILE ALSO SHARING THEIR KNOWLEDGE OF COLLABORATIVE SPECIALTY CARE FOR COMPLEX AIRWAY SURGERIES WITH LOCAL HEALTHCARE TEAMS. - NICOLAS Y. BUSABA, M.D., F.A.C.S., LEADS A TEACHING INITIATIVE WITH THE MINISTRY OF HEALTH IN KUWAIT FOR A FIVE-YEAR COLLABORATION WITH THE DEPARTMENT OF OTOLARYNGOLOGY AT THE MASSACHUSETTS EYE AND EAR INFIRMARY. - MICHAEL COHEN, M.D., SERVED ON A MEDICAL MISSION TO ADDIS ABABA, ETHIOPIA IN OCTOBER 2012, ALONG WITH MEEI AUDIOLOGIST ANNMARIE HENNESSY AND SIX OTHER MEDICAL PROFESSIONALS FROM THE GROUP "HEALING THE CHILDREN," PROVIDING SURGICAL CARE TO CHILDREN WITH EAR DISEASE AS WELL AS BASIC OTOLOGIC CARE TO THE 150 CHILDREN AT THE MAKANISSA SCHOOL FOR THE DEAF. - RAMON A. FRANCO, JR., M.D., CONTINUES HIS BIANNUAL MEDICAL MISSION TO HONDURAS TO PERFORM AIRWAY RECONSTRUCTIVE SURGERY, TO ADDRESS VOICE PROBLEMS, AND TO CARE FOR PATIENTS WITH LARYNGEAL CANCER. DR. FRANCO SERVES AS A MENTOR TO SPECIALISTS IN HONDURAS AND TO TRAINEES IN THE COUNTRY'S ONLY ENT RESIDENCY PROGRAM. - GREGORY W. RANDOLPH, M.D., F.A.C.S. PERFORMED THE 3,000TH CASE OF INTRAOPERATIVE NERVE MONITORING DURING THYROID/PARATHYROID SURGERY, PLACING MASS. EYE AND EAR AT THE FOREFRONT OF NEURAL MONITORING EXPERIENCE WORLDWIDE. THE INTRAOPERATIVE NERVE MONITORING PROGRAM IS A JOINT EFFORT BY THE DEPARTMENTS OF OTOLARYNGOLOGY, ANESTHESIA AND AUDIOLOGY AT MASS. EYE AND EAR. RADIOLOGY: NEW RECRUITS: - HILARY KELLY, M.D., WAS HIRED AS A STAFF RADIOLOGIST AND WILL BE HERE 1 DAY/WEEK. DR. KELLY WILL ASSIST WITH ULTRASOUND EXPANSION PROJECT DUE TO POSITIVE VOLUME GROWTH. NEW EQUIPMENT AND TECHNOLOGY: - SUCCESSFUL IMPLEMENTATION OF A CERETOM-OTO CT SCANNING SYSTEM AT OUR NEW QUINCY SATELLITE IN NOVEMBER 2011. - A TRIAL OF AN INTRA-OPERATIVE CERETOM OTOSCAN CT SYSTEM WAS COMPLETED IN DECEMBER 2011. THE TRIAL WAS ENDED AND EQUIPMENT WAS RETURNED DUE TO LOW VOLUME NEEDS BY MEDICAL STAFF. - A TRIAL OF A 3D ACCUITOMO CT SYSTEM IS SCHEDULED TO END BY THE END OF NOVEMBER 2012. THIS SYSTEM WAS CAPABLE OF GOOD QUALITY TEMPORAL BONE SCANS BUT THE VOLUME OF CASES WAS NOT HIGH ENOUGH TO SUPPORT A CAPITAL PURCHASE. - PLANNING STAGES ARE UNDERWAY TO REPLACE THE EXISTING SIEMENS SOMATOM 40-SLICE CT SYSTEM THAT IS APPROACHING SEVEN YEARS OLD. THIS WILL BE ACCOMPLISHED BY THE END OF FY13. ANESTHESIOLOGY: NEW RECRUITS: - AMIR GHOLAMI, MD STAFF ANESTHESIOLOGIST (JULY) - BENJAMIN MIZELL, MD, STAFF ANESTHESIOLOGIST (AUGUST) - KATHRIN BOURDEU, MD, STAFF ANESTHESIOLOGIST (OCTOBER) - NITA SAHANI, MD, STAFF ANESTHESIOLOGIST (DECEMBER) - TERESA BEAN, MD, STAFF ANESTHESIOLOGIST (FEBRUARY 2013) - CASEY BRACHVOGEL, CRNA, STAFF NURSE ANESTHETIST (AUGUST) NEW EQUIPMENT/TECHNOLOGY: THE ANESTHESIOLOGY DEPARTMENT PURCHASED 8 NEW PENLON ANESTHESIA MACHINES. |
Attach to Form 990 or Form 990-EZ. 
Attach to Form 990 or 990-EZ.